JP2018537421A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537421A5
JP2018537421A5 JP2018520394A JP2018520394A JP2018537421A5 JP 2018537421 A5 JP2018537421 A5 JP 2018537421A5 JP 2018520394 A JP2018520394 A JP 2018520394A JP 2018520394 A JP2018520394 A JP 2018520394A JP 2018537421 A5 JP2018537421 A5 JP 2018537421A5
Authority
JP
Japan
Prior art keywords
seq
cdr3
cdr1
cdr2
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018520394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018537421A (ja
JP7084870B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/075558 external-priority patent/WO2017068186A1/en
Publication of JP2018537421A publication Critical patent/JP2018537421A/ja
Publication of JP2018537421A5 publication Critical patent/JP2018537421A5/ja
Application granted granted Critical
Publication of JP7084870B2 publication Critical patent/JP7084870B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018520394A 2015-10-22 2016-10-24 Gitrアゴニスト Active JP7084870B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562245188P 2015-10-22 2015-10-22
US62/245,188 2015-10-22
US201662276352P 2016-01-08 2016-01-08
US62/276,352 2016-01-08
PCT/EP2016/075558 WO2017068186A1 (en) 2015-10-22 2016-10-24 Gitr agonists

Publications (3)

Publication Number Publication Date
JP2018537421A JP2018537421A (ja) 2018-12-20
JP2018537421A5 true JP2018537421A5 (https=) 2019-11-07
JP7084870B2 JP7084870B2 (ja) 2022-06-15

Family

ID=57211500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018520394A Active JP7084870B2 (ja) 2015-10-22 2016-10-24 Gitrアゴニスト

Country Status (8)

Country Link
US (2) US11059899B1 (https=)
EP (1) EP3365371B1 (https=)
JP (1) JP7084870B2 (https=)
CN (1) CN108473579B (https=)
AU (1) AU2016341403B2 (https=)
CA (1) CA3002711A1 (https=)
ES (1) ES3057922T3 (https=)
WO (1) WO2017068186A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018000948A (es) * 2015-07-23 2018-09-27 Inhibrx Inc Proteinas de fusion que se unen a gitir multivalentes y multiespecificas.
EP3365371B1 (en) 2015-10-22 2025-10-08 Ablynx NV Gitr agonists
EP3464360B1 (en) 2016-05-27 2025-11-12 Agenus Inc. Anti-tim-3 antibodies and methods of use thereof
JP2019519536A (ja) 2016-07-01 2019-07-11 ファイブ プライム セラピューティクス, インコーポレイテッド Gitrアゴニストおよびcpgを用いた組み合わせ抗腫瘍療法
JP7066696B2 (ja) 2016-10-11 2022-05-13 アジェナス インコーポレイテッド 抗lag-3抗体及びその使用方法
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症
WO2019001559A1 (zh) 2017-06-30 2019-01-03 江苏恒瑞医药股份有限公司 抗gitr抗体、其抗原结合片段及其医药用途
CN110357958A (zh) * 2018-03-26 2019-10-22 信达生物制药(苏州)有限公司 抗糖皮质激素诱导的肿瘤坏死因子受体(gitr)的小型化抗体、其聚合物及应用
CN108640993B (zh) * 2018-06-06 2020-09-04 暨南大学 一种抗重组人碱性成纤维细胞生长因子纳米抗体及其应用
EP3827019A1 (en) 2018-07-24 2021-06-02 Inhibrx, Inc. Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the same
RU2734432C1 (ru) 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
IL293561A (en) 2019-12-06 2022-08-01 Ablynx Nv Polypeptides comprising immunoglobulin with one variable domain targeting TNFa and IL-23
AU2021350156A1 (en) * 2020-09-25 2023-06-08 Ablynx Nv Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
EP4263602A1 (en) * 2020-12-18 2023-10-25 Ablynx N.V. Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
CN112851811B (zh) * 2021-01-28 2022-08-09 姜国胜 一种cd44v6纳米抗体及其作为白血病研究试剂的应用
EP4339209A4 (en) * 2021-05-10 2025-05-28 MediMabbio Inc. ANTI-GITR ANTIBODIES AND THEIR USES
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
AU2023300419A1 (en) 2022-07-01 2025-01-02 Transgene Fusion protein comprising a surfactant-protein-d and a member of the tnfsf
AR131494A1 (es) 2022-12-23 2025-03-26 Ablynx Nv Vehículos de conjugación a base de proteína
TW202448926A (zh) 2023-02-17 2024-12-16 比利時商艾伯霖克斯公司 結合新生兒fc受體之多肽
US20250270274A1 (en) * 2024-02-26 2025-08-28 Serpentide Inc. Super long-lasting glp1 or glp1/gip analogue drug for type-2 diabetes and obesity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1809589A (zh) * 2003-05-23 2006-07-26 Wyeth公司 Gitr配体和gitr配体相关分子和抗体及其应用
CN101218257A (zh) * 2005-03-25 2008-07-09 托勒克斯股份有限公司 Gitr结合分子及其用途
PT2343320T (pt) * 2005-03-25 2018-01-23 Gitr Inc Anticorpos anti-gitr e as suas utilizações
KR101790802B1 (ko) 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 항-gitr 항체
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
SI3148579T1 (sl) * 2014-05-28 2021-07-30 Agenus Inc. Proti GITR antitelesa in postopki z njihovo uporabo
PE20170441A1 (es) 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
MX2017015260A (es) * 2015-06-03 2018-02-19 Squibb Bristol Myers Co Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer.
MX2018000948A (es) 2015-07-23 2018-09-27 Inhibrx Inc Proteinas de fusion que se unen a gitir multivalentes y multiespecificas.
EP3365371B1 (en) 2015-10-22 2025-10-08 Ablynx NV Gitr agonists

Similar Documents

Publication Publication Date Title
JP2018537421A5 (https=)
JP7840836B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP2020500510A5 (https=)
JP2020506898A5 (https=)
JP2020515518A5 (https=)
JP2017519503A5 (https=)
JP2020195399A5 (https=)
JP2020515518A (ja) 改善された血清アルブミン結合剤
JP2019506841A5 (https=)
JP7821159B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
JP2019501883A5 (https=)
JP2017522903A5 (https=)
JP2011509245A5 (https=)
TW201643193A (zh) 一種抗pd-1的單克隆抗體及其獲得方法
JP2016524463A5 (https=)
IL317416A (en) T cell-recruiting polypeptides capable of binding CD123 and TCR alpha/beta
JP2019506839A (ja) 改善されたtnf結合因子
JP2005528914A5 (https=)
JP2021512159A5 (https=)
JP2022504826A5 (https=)
JP2025530888A5 (https=)
JP2015012869A5 (https=)
JP7821161B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
CA3164234A1 (en) Multi-specific antibodies